CVSA Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

120.260

Open

118.300

VWAP

118.90

Vol

471.57K

Mkt Cap

4.06B

Low

117.155

Amount

56.07M

EV/EBITDA(TTM)

10.23

Total Shares

34.03M

EV

4.41B

EV/OCF(TTM)

10.84

P/S(TTM)

2.27

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.

Show More

Events Timeline

(ET)

2026-05-07

16:40:00

Raises FY Revenue Outlook to $1.93B-$1.945B

2026-05-07

16:40:00

Covista Reports Q3 Revenue of $487.03M, Exceeds Expectations

2026-04-23 (ET)

2026-04-23

08:10:00

Covista Announces 97% First-Time Residency Rate for 2025-2026 Graduates

2026-04-13 (ET)

2026-04-13

08:20:00

Covista Appoints Amelia Manning as President of Chamberlain University

2026-04-06 (ET)

2026-04-06

08:10:00

Covista Appoints Michael Betz as Chief Growth & Innovation Officer

News

Fool

Covista Executive's Share Sale Raises Eyebrows

NASDAQ.COM

06-18NASDAQ.COM

Covista Executive's Share Sale Raises Concerns

Yahoo Finance

06-05Yahoo Finance

Analysis of Three Stocks Capturing Wall Street's Attention

Yahoo Finance

05-18Yahoo Finance

Covista Surpasses Q1 Expectations with Strong Enrollment Growth

Fool

MNDY Surges on AI-Driven Efficiency Gain

seekingalpha

05-08seekingalpha

Covista Reports Strong Quarterly Results and Raises Annual Guidance

0 Analyst Rating

Wall Street analysts forecast CVSA stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

Truist

Buy

maintain

$130 -> $140

AI Analysis

2026-05-11

Reason

Truist

Price Target

$130 -> $140

AI Analysis

2026-05-11

maintain

Buy

Reason

Truist raised the firm's price target on Covista to $140 from $130 and keeps a Buy rating on the shares after its Q3 earnings beat. The firm is citing the company having returned the Chamberlain segment to y/y enrollment growth a quarter early.

Truist

Buy

initiated

$130

2026-03-24

Reason

Truist

Price Target

$130

2026-03-24

initiated

Buy

Reason

Truist initiated coverage of Covista, formerly Adtalem, with a Buy rating and $130 price target. The company's clinical healthcare-focused institutions should benefit from labor shortages and upskilling trends, the analyst tells investors in a research note. Truist sees a "favorable catalyst path" for the shares in the coming months, saying Covista's mix towards clinical fields are largely insulated from AI disruption. In addition, early indications Chamberlain starts "could turn the corner," contends Truist.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CVSA

Unlock Now

Valuation Metrics

The current forward P/E ratio for Covista Inc (CVSA.N) is 13.30, compared to its 5-year average forward P/E of 14.66. For a more detailed relative valuation and DCF analysis to assess Covista Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

14.66

Current PE

13.30

Overvalued PE

16.43

Undervalued PE

12.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

9.19

Current EV/EBITDA

9.67

Overvalued EV/EBITDA

10.01

Undervalued EV/EBITDA

8.36

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

1.96

Current PS

1.95

Overvalued PS

2.10

Undervalued PS

1.82

Financials

AI Analysis

Annual

Quarterly

Whales Holding CVSA

Ariel Investments, LLC

ÖKoworld Lux S.A.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Covista Inc (CVSA) stock price today?

The current price of CVSA is 119.28 USD — it has increased 0.18

What is Covista Inc (CVSA)'s business?

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.

What is the price predicton of CVSA Stock?

Wall Street analysts forecast CVSA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVSA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Covista Inc (CVSA)'s revenue for the last quarter?

Covista Inc revenue for the last quarter amounts to 487.03M USD, increased 4.50

What is Covista Inc (CVSA)'s earnings per share (EPS) for the last quarter?

Covista Inc. EPS for the last quarter amounts to 1.20 USD, decreased -24.53

How many employees does Covista Inc (CVSA). have?

Covista Inc (CVSA) has 4703 emplpoyees as of June 23 2026.

What is Covista Inc (CVSA) market cap?

Today CVSA has the market capitalization of 4.06B USD.